RxDoctor Payments DataLook up a doctor →

Diogo Belo

Nephrology · Chula Vista, CANPI 1326043027

Payments from drug & device makers

$1,113,055in general payments, 2019–2025

Across 386 payments — averaging $2883.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$493K
  • Bayer$328K
  • Akebia Therapeutics Inc$135K
  • Sanofi US Services Inc.$53K
  • Gilead$35K
  • AbbVie$35K
  • plus $34K from 24 others

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK50$492,848
Bayer76$328,004
Akebia Therapeutics Inc120$134,647
Sanofi US Services Inc.9$52,907
Gilead8$35,170
AbbVie1$35,083
Novo Nordisk AS45$18,804
Lexicon Pharmaceuticals, Inc.2$9,732
EMD Serono, Inc.5$3,912
Otsuka America Pharmaceutical, Inc.14$368
Amgen(2 entities)6$251
AstraZeneca(2 entities)4$187
Mallinckrodt Enterprises LLC8$174
Lilly USA, LLC8$138
Amarin Pharma, Inc.3$125
Sanofi1$123
OPKO Pharmaceuticals, LLC6$118
Nxstage Medical, Inc.1$107
Shire North American Group Inc5$91
Vifor Pharma, Inc.2$44
Fresenius USA Marketing, Inc.2$38
Daiichi Sankyo Inc.2$38
Mallinckrodt Hospital Products Inc.1$25
AMAG Pharmaceuticals, Inc.1$22
Johnson & Johnson1$20
Takeda Pharmaceuticals U.S.A., Inc.1$20
Merck1$17
Cumberland Pharmaceuticals, Inc.1$16
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$14
Alnylam Pharmaceuticals Inc.1$14

How this compares

$1,113,055 in reported general payments places this provider in the 95th percentile of 1,341 nephrology providers in California.

See all nephrology providers in California →

Other nephrology in Chula Vista

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →